open access publication

Article, 2023

Comparable roles for serotonin in rats and humans for computations underlying flexible decision-making

Neuropsychopharmacology, ISSN 0893-133X, 1740-634X, Volume 49, 3, Pages 600-608, 10.1038/s41386-023-01762-6

Contributors

Luo, Qiang 0000-0002-0426-6039 (Corresponding author) [1] [2] Kanen, Jonathan W 0000-0002-4095-5405 [1] Bari, Andrea [3] Skandali, Nikolina G 0000-0002-2024-2256 [1] [4] [5] Langley, Christelle 0000-0001-5061-2820 [1] Knudsen, Gitte Moos 0000-0003-1508-6866 [6] [7] Alsiö, Johan [1] Phillips, Benjamin U [1] Sahakian, Barbara Jacquelyn [1] [2] Cardinal, Rudolf N 0000-0002-8751-5167 [1] [5] Robbins, Trevor W 0000-0003-0642-5977 (Corresponding author) [1] [2]

Affiliations

  1. [1] University of Cambridge
  2. [NORA names: United Kingdom; Europe, Non-EU; OECD];
  3. [2] Fudan University
  4. [NORA names: China; Asia, East];
  5. [3] Aelis Farma, 33077, Bordeaux, France
  6. [NORA names: France; Europe, EU; OECD];
  7. [4] NIHR Cambridge Dementia Biomedical Research Unit
  8. [NORA names: United Kingdom; Europe, Non-EU; OECD];
  9. [5] Cambridgeshire and Peterborough NHS Foundation Trust
  10. [NORA names: United Kingdom; Europe, Non-EU; OECD];

Abstract

Serotonin is critical for adapting behavior flexibly to meet changing environmental demands. Cognitive flexibility is important for successful attainment of goals, as well as for social interactions, and is frequently impaired in neuropsychiatric disorders, including obsessive–compulsive disorder. However, a unifying mechanistic framework accounting for the role of serotonin in behavioral flexibility has remained elusive. Here, we demonstrate common effects of manipulating serotonin function across two species (rats and humans) on latent processes supporting choice behavior during probabilistic reversal learning, using computational modelling. The findings support a role of serotonin in behavioral flexibility and plasticity, indicated, respectively, by increases or decreases in choice repetition (‘stickiness’) or reinforcement learning rates following manipulations intended to increase or decrease serotonin function. More specifically, the rate at which expected value increased following reward and decreased following punishment (reward and punishment ‘learning rates’) was greatest after sub-chronic administration of the selective serotonin reuptake inhibitor (SSRI) citalopram (5 mg/kg for 7 days followed by 10 mg/kg twice a day for 5 days) in rats. Conversely, humans given a single dose of an SSRI (20 mg escitalopram), which can decrease post-synaptic serotonin signalling, and rats that received the neurotoxin 5,7-dihydroxytryptamine (5,7-DHT), which destroys forebrain serotonergic neurons, exhibited decreased reward learning rates. A basic perseverative tendency (‘stickiness’), or choice repetition irrespective of the outcome produced, was likewise increased in rats after the 12-day SSRI regimen and decreased after single dose SSRI in humans and 5,7-DHT in rats. These common effects of serotonergic manipulations on rats and humans—identified via computational modelling—suggest an evolutionarily conserved role for serotonin in plasticity and behavioral flexibility and have clinical relevance transdiagnostically for neuropsychiatric disorders.

Keywords

SSRIs, administration, attainment, attainment of goals, behavior, behavioral flexibility, choice, choice behavior, citalopram, clinical relevance, cognitive flexibility, computational model, computer, decision-making, decreased serotonin function, demand, disorders, dose, effect, effects of serotonergic manipulations, environmental demands, findings, flexibility, flexible decision-making, framework, function, goal, humans, increase, inhibitors, interaction, latent process, learning, learning rate, manipulation, mechanistic framework, model, neurons, neuropsychiatric disorders, neurotoxin, neurotoxin 5,7-dihydroxytryptamine, obsessive-compulsive disorder, outcomes, plasticity, probabilistic reversal learning, process, punishment, rate, rats, regimen, reinforcement, relevance, repetition, reuptake inhibitors, reversal learning, reward, reward learning rate, serotonergic manipulations, serotonergic neurons, serotonin, serotonin function, serotonin reuptake inhibitors, serotonin signaling, signal, social interaction, species, sub-chronic administration

Funders

  • Department of Health and Social Care
  • National Natural Science Foundation of China
  • Lundbeck Foundation
  • National Institute for Health and Care Research
  • National Institute of Mental Health
  • Ministry of Science and Technology of the People's Republic of China
  • Medical Research Council
  • AstraZeneca (United Kingdom)
  • Wellcome Trust

Data Provider: Digital Science